A judge has found mining tool company Globaltech and mineral exploration company Boart Longyear infringed a patent for a mining tool owned by Australian Mud Company.
US-based multinational firm Jones Day has lured a partner from Clayton Utz to join its intellectual property team in Melbourne.
A judge has dismissed the majority of Microsoft’s six-year-old intellectual property suit against a Melbourne computer retailer over its Windows 7 software, which previously netted the Silicon Valley giant a $2.8 million payout from Judge Sandy Street that was slammed as a “regrettable” judicial failure.
Cable TV giant Foxtel has lost a protracted IP battle with subsidiary of global tech giant Cognizant over a digital download patent for a modern DVR system.
A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.
A judge has struck out claims accusing Corelogic of unauthorised scraping of confidential information from building information provider BCI Media’s copyright-protected leads platform, finding the case was “defective and deficient in many respects”.
IP firm Pizzeys Patent and Trade Mark Attorneys has dropped a lawsuit accusing two of its former lawyers who left to form a competing boutique of violating non-compete clauses in their employment contracts.
Animal-free dairy and protein company Perfect Day is trying again to patent a composition that it says makes superior vegan cheese and butter, after New Zealand dairy company Fonterra succeeded in opposing its bid to patent the invention.
The Corner Hotel has lost another bid to cancel a rival club’s ‘jazz corner’ and ‘jazz corner hotel’ trade marks, with a judge finding the marks did not infringe the famed Richmond pub’s ‘corner’ trade marks.
German biotech Fresenius Kabi has struck back at Samsung Bioepis’s latest attack on the validity of its patents for a liquid formulation of top selling immunosuppressant drug Humira, accusing the Korean company of causing its sales to flag by infringing the patent.